Roehrborn C - Search Results

1

Barry M, Roehrborn C, Webber R. Barry M, et al. Among authors: roehrborn c. Clin Evid. 2002 Dec;(8):849-63. Clin Evid. 2002. Update in: Clin Evid. 2003 Dec;(10):977-93. PMID: 12603916 Updated. Review. No abstract available.

2

Management of benign prostatic hyperplasia.

Barry M, Roehrborn C. Barry M, et al. Among authors: roehrborn c. Annu Rev Med. 1997;48:177-89. doi: 10.1146/annurev.med.48.1.177. Annu Rev Med. 1997. PMID: 9046954 Review.

3

Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.

McNeill SA, Hargreave TB, Geffriaud-Ricouard C, Santoni J, Roehrborn CG. McNeill SA, et al. Among authors: roehrborn cg. Urology. 2001 Mar;57(3):459-65. doi: 10.1016/s0090-4295(00)01021-9. Urology. 2001. PMID: 11248620

4

Benign prostatic hyperplasia.

Barry MJ, Roehrborn CG. Barry MJ, et al. Among authors: roehrborn cg. BMJ. 2001 Nov 3;323(7320):1042-6. doi: 10.1136/bmj.323.7320.1042. BMJ. 2001. PMID: 11691764 Free PMC article. Review. No abstract available.

5

Benign prostatic hyperplasia.

Barry M, Roehrborn C. Barry M, et al. Among authors: roehrborn c. Clin Evid. 2002 Jun;(7):775-87. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):849-63. PMID: 12230703 Updated. Review. No abstract available.

6

Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor.

O'Leary MP, Roehrborn C, Andriole G, Nickel C, Boyle P, Höfner K. O'Leary MP, et al. Among authors: roehrborn c. BJU Int. 2003 Aug;92(3):262-6. doi: 10.1046/j.1464-410x.2003.04310.x. BJU Int. 2003. PMID: 12887480 Clinical Trial.

7

The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.

Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S. Wilt TJ, et al. Among authors: roehrborn c. Contemp Clin Trials. 2009 Jan;30(1):81-7. doi: 10.1016/j.cct.2008.08.002. Epub 2008 Aug 23. Contemp Clin Trials. 2009. PMID: 18783735 Clinical Trial.

8

Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.

Lee J, Andriole G, Avins A, Crawford ED, Foster H, Kaplan S, Kreder K, Kusek J, McCullough A, McVary K, Meleth S, Naslund M, Nickel JC, Nyberg L, Roehrborn C, Dale Williams O, Barry M. Lee J, et al. Among authors: roehrborn c. Clin Trials. 2009 Dec;6(6):628-36. doi: 10.1177/1740774509352199. Epub 2009 Dec 9. Clin Trials. 2009. PMID: 20007408 Free PMC article.

9

Update on AUA guideline on the management of benign prostatic hyperplasia.

McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE Jr, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT. McVary KT, et al. Among authors: roehrborn cg. J Urol. 2011 May;185(5):1793-803. doi: 10.1016/j.juro.2011.01.074. Epub 2011 Mar 21. J Urol. 2011. PMID: 21420124

10

The relationship between lower urinary tract symptom severity and sleep disturbance in the CAMUS trial.

Helfand BT, McVary KT, Meleth S, Sharp V, Foster H, Naslund M, Williams OD; CAMUS Study Group. Helfand BT, et al. J Urol. 2011 Jun;185(6):2223-8. doi: 10.1016/j.juro.2011.02.012. Epub 2011 Apr 17. J Urol. 2011. PMID: 21497839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters